MS Islam, A Ciavattini, F Petraglia… - Human reproduction …, 2018 - academic.oup.com
BACKGROUND Uterine leiomyoma (also known as fibroid or myoma) is the most common benign tumor of the uterus found in women of reproductive age. It is not usually fatal but can …
BD Yilmaz, SE Bulun - Human reproduction update, 2019 - academic.oup.com
BACKGROUND Endometriosis is recognized as a steroid-dependent disorder; however, the precise roles of nuclear receptors (NRs) in steroid responsiveness and other signaling …
J Donnez, MM Dolmans - Human reproduction update, 2016 - academic.oup.com
Uterine fibroids (also known as leiomyomas or myomas) are the most common form of benign uterine tumors. Clinical presentations include abnormal bleeding, pelvic masses …
J Donnez, O Donnez, D Matule, HJ Ahrendt… - Fertility and sterility, 2016 - Elsevier
Objective To investigate the efficacy and safety of repeated 12-week courses of 5 or 10 mg daily ulipristal acetate for intermittent treatment of symptomatic uterine fibroids. Design …
GS Sohn, SH Cho, YM Kim, CH Cho… - Obstetrics & …, 2018 - synapse.koreamed.org
Uterine fibroids (leiomyomas or myomas), benign monoclonal tumors, are the most common benign tumors in women. Heavy or prolonged menstrual bleeding, abnormal uterine …
Highlights•Both estradiol and progesterone are essential for uterine fibroid development.•Ovarian blockade arrests leiomyoma growth, but it has many side …
Selective progesterone receptor modulators (SPRMs) are a new class of compounds developed to target the progesterone receptor (PR) with a mix of agonist and antagonist …
G Brichant, I Laraki, L Henry, C Munaut… - International journal of …, 2021 - mdpi.com
Endometriosis is defined as endometrial-like tissue outside the uterine cavity. It is a chronic inflammatory estrogen-dependent disease causing pain and infertility in about 10% of …
JL Magnay, S O'Brien, C Gerlinger, C Seitz - BMC women's health, 2020 - Springer
Background Pictorial blood loss assessment charts (PBACs) represent the most widely used method to assess menstrual blood loss (MBL) in clinical trials. The aims of this review were …